Betaloc-100mg Tab 10s
MRP: ₹78.30
Packaging
10 TAB
Composition
Metoprolol 100mg
Company
Astra Zeneca
MRP: ₹78.30
Packaging
10 TAB
Composition
Metoprolol 100mg
Company
Astra Zeneca
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Embeta 100 mg Tablet 10s | Intas | ₹33.94 | Save ₹44.36 |
| Metolar 100 mg Capsule 10s | Cipla | ₹61.00 | Save ₹17.30 |
| Lopresor 100mg Tablet 10s | Novartis India | ₹86.60 | — |
| Actiblok-100 IPR Tab | Biocon Ltd | ₹95.00 | — |
| Starpress XL 100mg Tablet 10s | Lupin | ₹102.25 | — |
| Betaone XL-100 Tab | Dr. Reddy | ₹108.50 | — |
| Embeta XR 100 mg Tablet 10s | INTAS | ₹110.00 | — |
| Prolomet XL 100mg Tablet 10s | Sun Pharma | ₹117.00 | — |
| Metocard Xl 100mg Tablet 10s | Torrent Pharma | ₹118.70 | — |
| Supermet XL 100 Tablet | Abbott India | ₹119.10 | — |
| Tolol Xr 100mg Tablet 10s | Unichem | ₹122.80 | — |
| Metzok 100mg Tablet 10s | USV | ₹123.25 | — |
| Vinicor-XL 100 Tab | Ipca Labs | ₹123.30 | — |
| Revelol XL-100 Tab | Ipca Labs | ₹123.42 | — |
| Cardibeta-100 Cap | Ranbaxy | ₹131.99 | — |
| Metolar XR 100 mg Capsule 10s | Cipla | ₹139.00 | — |
| Metox ER 100mg Tablet 14s | Wockhardt | ₹146.02 | — |
| Seloken XL 100mg Tablet 15s | ASTRA ZENECA | ₹159.25 | — |
Metoprolol, which is the generic form of Lopressor is not only used to treat hypertension.
Dizziness, insomnia, tiredness, headache, vertigo, confusion, bradycardia, shortness of breath, hypotension, Raynaud's phenomenon, CHF, peripheral oedema, cold extremities, syncope, chest pain, palpitations, gangrene, claudication, hallucinations, nightmares, visual disturbances; diarrhoea, constipation, flatulence, GI pain, heartburn, nausea, hiccups, xerostomia; bronchoconstriction, wheezing, dyspnoea; dry skin, maculopapular, psoriasiform, pruritus, worsening of psoriasis, urticarial rash. Rarely, Peyronie's disease, tinnitus, restless legs, musculoskeletal pain, a polymyalgia-like syndrome, decreased libido, blurred vision, dry mucous membranes, sweating; reversible alopecia, thrombocytopenia, agranulocytosis, retroperitoneal fibrosis, wt gain, arthritis, dry eyes.
Additive effect w/ catecholamine-depleting drugs (e.g. reserpine) and MAOIs. May antagonise β1-adrenergic stimulating effects of sympathomimetics. Additive negative effects on SA or AV nodal conduction w/ cardiac glycosides, nondihydropyridine Ca channel blockers. Paradoxical response to epinephrine may occur. Increased plasma concentrations w/ CYP2D6 inhibitors (e.g. bupropion, cimetidine). Increased risk of hypotension and heart failure w/ myocardial depressant general anaesth (e.g. diethyl ether). Risk of pulmonary HTN w/ vasodilators (e.g. hydralazine) in uraemic patients. Reduced plasma levels w/ rifampicin. May increase negative inotropic and negative dromotropic effect of antiarrhythmic drugs (e.g. quinidine, amiodarone). May reduce antihypertensive efficacy w/ indometacin. May increase effects of hypoglycaemics.
2nd or 3rd degree AV block, sick sinus syndrome, hypotension, decompensated heart failure, sinus bradycardia, severe peripheral arterial circulatory disorders, cardiogenic shock, severe asthma and bronchospasm, untreated phaeochromocytoma, Prinzmetal's angina, metabolic acidosis.
Metoprolol selectively inhibits β1-adrenergic receptors but has little or no effect on β2-receptors except in high doses. It does not exhibit membrane stabilising or intrinsic sympathomimetic activity. Onset: 1-2 hr (oral); 20 min, when infused over 10 min (IV). Duration: Oral: Approx 3-6 hr (immediate release); approx 24 hr (extended release). IV: 5-8 hr. Absorption: Absorbed readily and completely from the GI tract. Bioavailability increased by food. Bioavailability: Approx 50%. Time to peak plasma concentration: Approx 1.5-2 hr (oral). Distribution: Widely distributed, enters breast milk, crosses the placenta and blood-brain barrier. Volume of distribution: 3.2-5.6 L/kg. Plasma protein binding: Approx 12%. Metabolism: Extensively hepatic via CYP2D6 isoenzyme and undergoes oxidative deamination, O-dealkylation followed by oxidation and aliphatic hydroxylation. Excretion: Via urine (as metabolites and unchanged drug). Elimination half-life: 3-4 hr (fast hydroxylators); approx 7 hr (poor hydroxylators).
Patients w/ myasthenia gravis, well-compensated heart failure, bronchospastic disease, AV conduction disorders, substantial cardiomegaly. May mask signs and symptoms of hyperthyroidism and hypoglycaemia. Patients w/ history of cardiac failure or those w/ minimal cardiac reserve. Patients undergoing major surgery involving general anaesth. Avoid abrupt withdrawal as it may precipitate thyroid storm or MI, and may exacerbate angina and ventricular arrhythmias. Hepatic impairment. Pregnancy and lactation. Patient Counselling May affect ability to drive or operate machinery. Monitoring Parameters Monitor BP, ECG and heart rate.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Actamase 1000 mg/125 mg Injection | INJECTION | ₹505.50 |
| Actamase Forte 2 gm Injection | INJECTION | ₹850.00 |
| Arimidex 1 mg Tablet 14s | TAB | ₹3,435.00 |
| Betaloc H 100/12.5mg Tab 10s | TAB | ₹40.00 |
| Betaloc H 50/12.5mg Tab 10s | TAB | ₹30.80 |
| Betaloc Injection 5ml | INJECTION | ₹15.10 |
| Betaloc-100mg Tab 10s | TAB | ₹78.30 |
| Betaloc-25mg Tab 30s | TAB | ₹94.50 |
| Betaloc-50mg Tab 30s | TAB | ₹143.40 |
| Bricanyl Inhaler | INHALER | ₹0.00 |
| Bricanyl Injection | INJECTION | ₹12.39 |
| Bricanyl Nebulising Solution 10ml | SOLUTION | ₹39.70 |
| Bricanyl Syrup 100ml | SYRUP | ₹37.20 |
| Bricanyl-2.5mg Tab 20s | TAB | ₹19.80 |
| Bricanyl-5mg Tab 20s | TAB | ₹34.90 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist